20th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), Vienna, Avusturya, 26 - 29 Ağustos 2015, ss.105-110, (Tam Metin Bildiri)
Introduction: Non-alcoholic fatty liver disease is associated with like other insulin resistance syndromes with obesity, hypertriglyceridemia, diabetes and hypertension metformin is known to restrict hepatic gluconeogenesis and reduces glycogenolysis.